PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
1-Year Return
73.17%
This Quarter Return
+25.01%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$1.53B
AUM Growth
+$286M
(+23%)
Cap. Flow
+$58.8M
Cap. Flow
% of AUM
3.83%
Top 10 Holdings %
Top 10 Hldgs %
51.28%
Holding
202
New
47
Increased
40
Reduced
35
Closed
31
Top Buys
| 1 |
RXDX
Ignyta, Inc.
RXDX
|
$29.7M |
| 2 |
Sarepta Therapeutics
SRPT
|
$18.4M |
| 3 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
$17.9M |
| 4 |
Viatris
VTRS
|
$14.3M |
| 5 |
Heron Therapeutics
HRTX
|
$14M |
Top Sells
| 1 |
Neurocrine Biosciences
NBIX
|
$21.8M |
| 2 |
BLUE
bluebird bio
BLUE
|
$16.3M |
| 3 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$11.1M |
| 4 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$11M |
| 5 |
uniQure
QURE
|
$10.5M |
Sector Composition
| 1 | Healthcare | 83.91% |
| 2 | Financials | 0.1% |
| 3 | Technology | 0.06% |
| 4 | Consumer Discretionary | 0.06% |
| 5 | Energy | 0.01% |
